If there was a very strong RBS site placed between the promoter and the AUG of the fusion partner at the N terminal, while there would also be the Shine-Dalgarno sequence placed in between the protein of interest and that N-terminal fusion partner. What effect would that have on the expression? would you expect to see a heterogenous protein expression where there would be some full length fusion protein expressed, as well as some expression of the protein of interest without the fusion partner?